Capricor Therapeutics Inc

€25.06
EUR
Last updated on --.
24h volume553.61K
24h highest25.6882 EUR
24h lowest24.8282 EUR
24h Price movement-0.75%

CAPR recent prices

24 Hours
-0.75%-€0.1892
30 days
-13.88%-€4.058
60 days
+5.37%+€1.283
90 days
+4.77%+€1.145

Key data

Previous close25.2496 EUR
Market cap1.44B EUR
Volume553.61K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.7028 EUR
Net income (FY)-98.55M EUR
Revenue (FY)--
Last report dateMay 13, 2026

About Capricor Therapeutics Inc

PHARMACEUTICAL PREPARATIONS
HeadquartersSAN DIEGO
Employees (FY)231.00
Net income per employee (FY)-426.63K EUR
Listed onNasdaq
Official website

CAPR conversion tables

CAPRCAPR
EUREUR
0.5 CAPR12.53 EUR
1 CAPR25.06 EUR
5 CAPR125.3 EUR
10 CAPR250.6 EUR
EUREUR
CAPRCAPR
0.5 EUR0.019952 CAPR
1 EUR0.039904 CAPR
5 EUR0.19952 CAPR
10 EUR0.39904 CAPR

FAQ

CAPR is trading at €25.06, -0.75% over the last 24 hours. Track live moves on the price chart at the top of this page.
The CAPR stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. CAPR is currently trading at €25.06, -0.75% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on CAPR price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. CAPR's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from CAPR; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against CAPR's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Capricor Therapeutics Inc's market cap is currently 1.44B EUR. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume553.61K
24h highest25.6882 EUR
24h lowest24.8282 EUR
24h Price movement-0.75%
CAPRCAPR
EUREUR
Start trade with CAPR Perpetual